Enhanced Recovery From Contraction-Induced Damage in Skeletal Muscles of Old Mice Following Treatment With the Heat Shock Protein Inducer 17-(Allylamino)-17-Demethoxygeldanamycin

Rejuvenation Research - United States
doi 10.1089/rej.2008.0795
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Novel Mechanism of Attenuation of LPS-Induced NF-κB Activation by the Heat Shock Protein 90 Inhibitor, 17-N-Allylamino-17-Demethoxygeldanamycin, in Human Lung Microvascular Endothelial Cells

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2014English

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator

Clinical Cancer Research
Cancer ResearchOncology
2004English

Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients With Refractory Advanced Cancers

Clinical Cancer Research
Cancer ResearchOncology
2005English

Sulforaphane Potentiates the Efficacy of 17-Allylamino 17-Demethoxygeldanamycin Against Pancreatic Cancer Through Enhanced Abrogation of Hsp90 Chaperone Function

Nutrition and Cancer
MedicineNutritionOncologyCancer ResearchDietetics
2011English

17-Allylamino-17-Demethoxygeldanamycin Down-Regulates Hyaluronic Acid-Induced Glioma Invasion by Blocking Matrix Metalloproteinase-9 Secretion

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2008English

Hsp70 Inducer, 17-Allylamino-Demethoxygeldanamycin, Provides Neuroprotection via Anti-Inflammatory Effects in a Rat Model of Traumatic Brain Injury

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors

Investigational New Drugs
OncologyPharmacology
2010English

Cooperative Enhancement of Radiosensitivity After Combined Treatment of 17-(Allylamino)-17-Demethoxygeldanamycin and Celecoxib in Human Lung and Colon Cancer Cell Lines

DNA and Cell Biology
MedicineGeneticsCell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy